Alphatec

ATEC

11.3700.70% ( -0.080 )

Closed: Oct 29, 16:00:00 (EDT)

Current ValuationThe current P/E ratio is -16.08, within the reasonable range, cheaper than 77.78% of the time in the past 1 years, and the industry ranks 145/174, the industry Median -0.80.

-16.08xP/E

Stock price$11.45Earnings per share$-0.71

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

014284256

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

0x30x60x90x120x150x

P/E ratio
Name/Symbol
BAXUSBaxter	-12.38x	140.96%	$13.16B
GKOSUSGlaukos	-63.02x	94.66%	$10.70B
TFXUSTeleflex	-5.71x	118.39%	$5.89B
IRTCUSIRhythm	-293.04x	71.47%	$4.09B
PLSEUSPulse Biosciences	-47.82x	26.85%	$3.83B
ASSTUSStrive	-3.50x	57.99%	$3.42B
AXGNUSAxogen	-90.52x	4.90%	$2.89B
BFLYUSButterfly Network	-27.78x	31.45%	$2.08B
ATECUSAlphatec	-16.08x	41.67%	$1.77B
KMTSUSKestra Medical Tech	-11.68x	0.79%	$1.75B
NVCRUSNovocure	-11.11x	1.23%	$1.65B
TNDMUSTandem Diabetes	-21.63x	77.60%	$1.37B
ENOVUSEnovis	-1.15x	100.97%	$1.26B
DRTSUSAlpha Tau Medical	-13.32x	--	$1.23B
PRCTUSPROCEPT BioRobotics	-10.54x	3.47%	$1.16B
AORTUSArtivion	-350.20x	266.67%	$1.12B
CBLLUSCeribell	-15.83x	35.15%	$1.04B
SIBNUSSI-BONE	-66.87x	8.85%	$978.39M
QDELUSQuidelOrtho	-0.92x	75.33%	$960.74M
BBNXUSBeta Bionics	-11.31x	13.70%	$939.66M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.